Abstract
Hematopoietic chimerism as a predictive marker for the relapse of acute leukemia after allogeneic BMT was evaluated in a prospective study. Monthly assays of hematopoietic chimerism were performed from peripheral blood samples by PCR amplification of short tandem repeats or amelogenin loci. Between December 1997 and June 1999, 33 patients enrolled and 30 were evaluable (two early deaths, one lack of informative bands for chimerism evaluation). There were 14 male and 16 female patients (15 AML and 15 ALL) with a median age of 31 years (range 16–46). Mixed chimerism (MC) was observed at least once in 14 of 30 patients (47%). There was no significant difference between 14 patients who showed MC (MC group) and 16 patients who did not show MC (complete chimerism (CC) group) in terms of age, sex, disease status at BMT, donor type, and the number of bone marrow cells infused. There was no significant difference in the neutrophil and platelet engraftment rates between the two groups. After a median follow up of 10.9 months (range 4.3–22.4), five patients in the CC group and two patients in the MC group relapsed (P = 0.27). All five patients who relapsed in the CC group maintained CC up to 1 month prior to clinical relapse. Our study demonstrated that the patients who showed MC post BMT did not have higher risk of relapse of acute leukemia when compared to patients who did not show MC. Sensitive PCR-based assays for hematopoietic chimerism applied on a monthly basis after allogeneic BMT could not predict relapse of acute leukemia. Bone Marrow Transplantation (2000) 26, 327–332.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hill RS, Petersen FB, Storb R et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease Blood 1986 67: 811–816
Roy DC, Tantravahi R, Murray C et al. Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium Blood 1990 75: 296–304
Frassoni F, Strada P, Sessarego M et al. Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host disease Bone Marrow Transplant 1990 5: 235–240
Bertheas MF, Lafage M, Levy P et al. Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia Blood 1991 78: 3103–3106
Bar BM, Schattenberg A, De Man AJ et al. Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow Bone Marrow Transplant 1992 10: 45–52.
Roux E, Helg C, Chapius B et al. Mixed chimerism after bone marrow transplantation and the risk of relapse (letter) Blood 1994 84: 4385–4386
Mackinnon S, Barnett L, Heller G, O'Reilly RJ . Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia Blood 1994 83: 3409–3416
Serrano J, Roman J, Herrera C et al. Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse Bone Marrow Transplant 1999 23: 475–482
Bader P, Holle W, Klingebiel T et al. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children Bone Marrow Transplant 1997 19: 697–702
Bader P, Beck J, Frey A et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT Bone Marrow Transplant 1998 21: 487–495
Ramirez M, Diaz MA, Garcia-Sanchez F et al. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia Bone Marrow Transplant 1996 18: 1161–1165
Suttorp M, Schmitz N, Dreger P et al. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms Leukemia 1993 7: 679–687
Molloy K, Goulden N, Lawler M et al. Patterns of hematopoietic chimerism following bone marrow transplantationfor childhood acute lymphoblastic leukemia from volunteerunrelated donors Blood 1996 87: 3027–3031
Lee J-H, Lee K-H, Kim S et al. Relevance of protein C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study Bone Marrow Transplant 1998 22: 883–888
Lee K-H, Lee J-H, Choi S-J et al. Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation Bone Marrow Transplant 1999 24: 591–599
Edwards A, Civitello A, Hammond HA, Caskey CT . DNA typing and genetic mapping with trimeric and tetrameric tandem repeats Am J Hum Genet 1991 49: 746–756
Hammond HA, Jin L, Zhong Y et al. Evaluation of 13 short tandem repeat loci for use in personal identification applications Am J Hum Genet 1994 55: 175–189
Anker R, Steinbrueck T, Donis-Keller H . Tetranucleotide repeat polymorphism at the human thyroid peroxidase (hTPO) locus Hum Mol Genet 1992 1: 137
Edwards A, Hammond HA, Jin L et al. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups Genomics 1992 12: 241–253
Kimpton C, Walton A, Gill P et al. A further tetranucleotide repeat polymorphism in the vWF gene Hum Mol Genet 1992 1: 287
Nishimura DY, Murray JC . A tetranucleotide repeat for the F13B locus Nucleic Acids Res 1992 20: 1167
Schlotterer C, Tautz D . Slippage synthesis of simple sequence DNA Nucleic Acids Res 1992 20: 211–215
Sullivan KM, Mannucci A, Kimpton CP, Gill P . A rapid and quantitative DNA sex test: fluorescence-based PCR analysis of X-Y homologous gene amelogenin Biotechniques 1993 15: 636–641
Bassam BJ, Caetano-Anolles G, Gresshoff PM . Fast and sensitive silver staining of DNA in polyacrylamide gels Anal Biochem 1991 196: 80–83
Thiede C, Florek M, Bornhauser M et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection Bone Marrow Transplant 1999 23: 1055–1060
Acknowledgements
This work was supported in part by a grant (No. 98–109) from the Research Fund for the Asan Institute for Life Science.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Choi, SJ., Lee, KH., Lee, JH. et al. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant 26, 327–332 (2000). https://doi.org/10.1038/sj.bmt.1702504
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702504
Keywords
This article is cited by
-
Chimerism analysis for clinicians: a review of the literature and worldwide practices
Bone Marrow Transplantation (2022)
-
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
Bone Marrow Transplantation (2020)
-
Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation
Bone Marrow Transplantation (2018)
-
Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia
Bone Marrow Transplantation (2007)
-
Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms
Leukemia (2005)